Bacteriophage Therapy

Antimicrobial Agents and Chemotherapy - Tập 45 Số 3 - Trang 649-659 - 2001
Alexander Sulakvelidze1, Zemphira Alavidze1,2, J. Glenn Morris1
1Division of Molecular Epidemiology, Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, Maryland 21201,1 and
2Eliava Institute of Bacteriophage, Microbiology, and Virology, Georgian Academy of Sciences, Tbilisi, Georgia 3800602

Tóm tắt

Từ khóa


Tài liệu tham khảo

Abdul-Hassan H. S. El-Tahan E. Massoud B. Gomaa R. Bacteriophage therapy of pseudomonas burn wound sepsis. Ann. Medit. Burn Club 3 1990 262 264

Adamia R. S. Matitashvili E. A. Kvachadze L. I. Korinteli V. I. Matoyan D. A. Kutateladze M. I. Chanishvili T. G. The virulent bacteriophage IRA of Salmonella typhimurium: cloning of phage genes which are potentially lethal for the host cell. J. Basic Microbiol. 10 1990 707 716

10.1016/S0163-4453(98)92874-2

Andriashvili I. A. Kvachadze L. I. Vashakidze R. P. Adamia R. S. Chanishvili T. G. Molecular mechanisms of DNA protection from restriction endonucleases in Staphylococcus aureus cells. Mol. Gen. Mikrobiol. Virusolol. 8 1986 43 45

Anonymous Phage therapy. Lancet iii 1983 1287 1288

Anpilov L. I. Prokudin A. A. Preventive effectiveness of dried polyvalent Shigella bacteriophage in organized collective groups. Voenno-Med. Zh. 5 1984 39 40

Babalova E. G. Katsitadze K. T. Sakvarelidze L. A. Imnaishvili N. S. Sharashidze T. G. Badashvili V. A. Kiknadze G. P. Meipariani A. N. Gendzekhadze N. D. Machavariani E. V. Gogoberidze K. L. Gozalov E. I. Dekanosidze N. G. Preventive value of dried dysentery bacteriophage. Zh. Mikrobiol. Epidemiol. Immunobiol. 2 1968 143 145

Barrow P. A. Soothill J. S. Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential. Trends Microbiol. 7 1997 268 271

10.1038/340467a0

Bogovazova G. G. Voroshilova N. N. Bondarenko V. M. The efficacy of Klebsiella pneumoniae bacteriophage in the therapy of experimental Klebsiella infection. Zh. Mikrobiol. Epidemiol. Immunobiol. 4 1991 5 8

Bogovazova G. G. Voroshilova N. N. Bondarenko V. M. Gorbatkova G. A. Afanas'eva E. V. Kazakova T. B. Smirnov V. D. Mamleeva A. G. Glukharev I. A. Erastova E. I. Krylov I. A. Ovcherenko T. M. Baturo A. P. Yalsyk G. V. Arefyeva N. A. Immunobiological properties and therapeutic effectiveness of preparations from Klebsiella bacteriophages. Zh. Mikrobiol. Epidemiol. Immunobiol. 3 1992 30 33

Bordet J. Ciuca M. Remarques sur l'historique de recherches concernant la lyse microbienne transmissible. Compt. Rend. Soc. Biol. 84 1921 745 747

Bruynoghe R. Maisin J. Essais de thérapeutique au moyen du bacteriophage. C. R. Soc. Biol. 85 1921 1120 1121

Carlton R. M. Phage therapy: past history and future prospects. Arch. Immunol. Ther. Exp. 5 1999 267 274

Chernomordik A. B. Bacteriophages and their therapeutic-prophylactic use. Med. Sestra 6 1989 44 47

10.1128/AAC.41.3.497

Cislo M. Dabrowski M. Weber-Dabrowska B. Woyton A. Bacteriophage treatment of suppurative skin infections. Arch. Immunol. Ther. Exp. 2 1987 175 183

D'Herelle F. Sur un microbe invisible antagoniste des bacilles dysentériques. C. R. Acad. Sci. (Paris) 165 1917 373 375

D'Herelle F. The bacteriophage and its clinical applications. 1930 Charles C Thomas Springfield Ill

Eaton M. D. Bayne-Jones S. Bacteriophage therapy. Review of the principles and results of the use of bacteriophage in the treatment of infections. JAMA 23 1934 1769 1939

Hankin E. H. L'action bactericide des eaux de la Jumna et du Gange sur le vibrion du cholera. Ann. Inst. Pasteur 10 1896 511

Ioseliani G. D. Meladze G. D. Chkhetiia N. S. Mebuke M. G. Kiknadze N. I. Use of bacteriophage and antibiotics for prevention of acute postoperative empyema in chronic suppurative lung diseases. Grudn. Khir. 6 1980 63 67

Kaczkowski H. Weber-Dabrowska B. Dabrowski M. Zdrojewicz Z. Cwioro F. Use of bacteriophages in the treatment of chronic bacterial diseases. Wiad. Lek. 43 1990 136 141

Kiknadze G. P. Gadua M. M. Tsereteli E. V. Mchedlidze L. S. Birkadze T. V. Efficiency of preventive treatment by phage preparations of children's hospital salmonellosis Intestinal infections. Kiknadze G. P. 1986 41 44 Sovetskaya Meditsina Tbilisi Georgia

Kochetkova V. A. Mamontov A. S. Moskovtseva R. L. Erastova E. I. Trofimov E. I. Popov M. I. Dzhubalieva S. K. Phagotherapy of postoperative suppurative-inflammatory complications in patients with neoplasms. Sov. Med. 6 1989 23 26

Krueger A. P. Scribner E. J. Bacteriophage therapy. II. The bacteriophage: its nature and its therapeutic use. JAMA 19 1941 2160 2277

Kucharewicz-Krukowska A. Slopek S. Immunogenic effect of bacteriophage in patients subjected to phage therapy. Arch. Immunol. Ther. Exp. 5 1987 553 561

Kutter E. Guttman B. Carlson K. The transition from host to phage metabolism after T4 infection Molecular biology of bacteriophage T4. Karam J. D. 1994 343 346 American Society for Microbiology Washington D.C.

Kwarcinski W. Lazarkiewicz B. Weber-Dabrowska B. Rudnicki J. Kaminski K. Sciebura M. Bacteriophage therapy in the treatment of recurrent subphrenic and subhepatic abscess with jejunal fistula after stomach resection. Pol. Tyg. Lek. 49 1994 535

Lang G. Kehr P. Mathevon H. Clavert J. M. Sejourne P. Pointu J. Bacteriophage therapy of septic complications of orthopaedic surgery. Rev. Chir. Orthop. Reparatrice Appar. Mot. 1 1979 33 37

10.1086/285884

Litvinova A. M. Chtetsova V. M. Kavtreva I. G. Evaluation of efficacy of the use of E. coli-Proteus bacteriophage in intestinal dysbacteriosis in premature infants. Vopr. Okhr. Materin. Det. 9 1978 42 44

Meladze G. D. Mebuke M. G. Chkhetia N. S. Kiknadze N. I. Koguashvili G. G. Timoshuk I. I. Larionova N. G. Vasadze G. K. The efficacy of staphylococcal bacteriophage in treatment of purulent diseases of lungs and pleura. Grudn. Khir. 1 1982 53 56

Merril C. R. Biswas B. Carlton R. Jensen N. C. Creed G. J. Zullo S. Adhya S. Long-circulating bacteriophage as antibacterial agents. Proc. Natl. Acad. Sci. USA 8 1996 3188 3192

Miliutina L. N. Vorotyntseva N. V. Current strategy and tactics of etiotropic therapy of acute intestinal infections in children. Antibiot. Khimioter. 1 1993 46 53

Ochs H. D. Buckley R. H. Kobayashi R. H. Kobayashi A. L. Sorensen R. U. Douglas S. D. Hamilton B. L. Hershfield M. S. Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency. Blood 5 1992 1163 1171

Ochs H. D. Nonoyama S. Zhu Q. Farrington M. Wedgewood R. J. Regulation of antibody responses: the role of complement and adhesion molecules. Clin. Immunol. Immunopathol. 67 1993 S33 S40

Pavlenishvili I. Tsertsvadze T. Bacteriophagotherapy and enterosorbtion in treatment of sepsis of newborns caused by gram-negative bacteria. Pren. Neon. Infect. 11 1993 104

Peremitina L. D. Berillo E. A. Khvoles A. G. Experience in the therapeutic use of bacteriophage preparations in suppurative surgical infections. Zh. Mikrobiol. Epidemiol. Immunobiol. 9 1981 109 110

Perepanova T. S. Darbeeva O. S. Kotliarova G. A. Kondrat'eva E. M. Maiskaia L. M. Malysheva V. F. Baiguzina F. A. Grishkova N. V. The efficacy of bacteriophage preparations in treating inflammatory urologic diseases. Urol. Nefrol. 5 1995 14 17

Pokrovskaya M. P. Kaganova L. C. Morosenko M. A. Bulgakova A. G. Skatsenko E. E. Treatment of wounds with bacteriophages 2nd ed. 1942 State Publishing House “Medgiz ” Moscow USSR

10.1128/AAC.38.6.1211

Proskurov V. A. Use of staphylococcal bacteriophage for therapeutic and preventive purposes. Zh. Mikrobiol. Epidemiol. Immunobiol. 2 1970 104 107

10.1097/00000441-193003000-00005

Sakandelidze V. M. Meipariani A. N. Use of combined phages in suppurative-inflammatory diseases. Zh. Mikrobiol. Epidemiol. Immunobiol. 6 1974 135 136

Sakandelidze V. M. The combined use of specific phages and antibiotics in different infectious allergoses. Vrach. Delo 3 1991 60 63

10.1128/AAC.41.11.2321

Samsygina G. A. Boni E. G. Bacteriophages and phage therapy in pediatric practice. Pediatria 4 1984 67 70

Schless R. A. Staphylococcus aureus meningitis: treatment with specific bacteriophage. Am. J. Dis. Child. 44 1932 813 822

Shabalova I. A. Karpanov N. I. Krylov V. N. Sharibjanova T. O. Akhverdijan V. Z. Pseudomonas aeruginosa bacteriophage in treatment of P. aeruginosa infection in cystic fibrosis patients Proceedings of IX International Cystic Fibrosis Congress. 1995 443 International Cystic Fibrosis Association Zurich Switzerland

10.1128/AAC.37.3.377

Slopek S. Durlakowa I. Weber-Dabrowska B. Kucharewicz-Krukowska A. Dabrowski M. Bisikiewicz R. Results of bacteriophage treatment of suppurative bacterial infections. I. General evaluation of the results. Arch. Immunol. Ther. Exp. 31 1983 267 291

Slopek S. Durlakowa I. Weber-Dabrowska B. Kucharewicz-Krukowska A. Dabrowski M. Bisikiewicz R. Results of bacteriophage treatment of suppurative bacterial infections. II. Detailed evaluation of the results. Arch. Immunol. Ther. Exp. 31 1983 293 327

Slopek S. Durlakowa I. Weber-Dabrowska B. Dabrowski M. Kucharewicz-Krukowska A. Results of bacteriophage treatment of suppurative bacterial infections. III. Detailed evaluation of the results obtained in a further 150 cases. Arch. Immunol. Ther. Exp. 32 1984 317 335

Slopek S. Kucharewicz-Krukowska A. Weber-Dabrowska B. Dabrowski M. Results of bacteriophage treatment of suppurative bacterial infections. IV. Evaluation of the results obtained in 370 cases. Arch. Immunol. Ther. Exp. 33 1985 219 240

Slopek S. Kucharewicz-Krukowska A. Weber-Dabrowska B. Dabrowski M. Results of bacteriophage treatment of suppurative bacterial infections. V. Evaluation of the results obtained in children. Arch. Immunol. Ther. Exp. 33 1985 241 259

Slopek S. Kucharewicz-Krukowska A. Weber-Dabrowska B. Dabrowski M. Results of bacteriophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative staphylococcal infections. Arch. Immunol. Ther. Exp. 33 1985 261 273

Slopek S. Weber-Dabrowska B. Dabrowski M. Kucharewicz-Krukowska A. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981–1986. Arch. Immunol. Ther. Exp. 35 1987 569 583

Smith H. W. Huggins M. B. Successful treatment of experimental Escherichia coli infections in mice using phages: its general superiority over antibiotics. J. Gen. Microbiol. 128 1982 307 318

Smith H. W. Huggins M. B. Effectiveness of phages in treating experimental E. coli diarrhoea in calves, piglets and lambs. J. Gen. Microbiol. 129 1983 2659 2675

Smith H. W. Huggins M. B. The control of experimental E. coli diarrhea in calves by means of bacteriophage. J. Gen. Microbiol. 133 1987 1111 1126

Smith H. W. Huggins M. B. Shaw K. M. Factors influencing the survival and multiplication of bacteriophages in calves and in their environment. J. Gen. Microbiol. 133 1987 1127 1135

Soothill J. S. Lawrence J. C. Ayliffe G. A. J. The efficacy of phages in the prevention of the destruction of pig skin in vitro by Pseudomonas aeruginosa. Med. Sci. Res. 16 1988 1287 1288

10.1099/00222615-37-4-258

10.1016/0305-4179(94)90184-8

Stout B. F. Bacteriophage therapy. Texas State J. Med. 29 1933 205 209

Stroj L. Weber-Dabrowska B. Partyka K. Mulczyk M. Wojcik M. Successful treatment with bacteriophage in purulent cerebrospinal meningitis in a newborn. Neurol. Neurochir. Pol. 3 1999 693 698

Summers W. C. Felix d'Herelle and the origins of molecular biology. 1999 Yale University Press New Haven Conn

Tolkacheva T. V. Abakumov E. M. Martynova V. A. Golosova T. V. Correction of intestinal dysbacteriosis with biological preparations in acute leukemia. Probl. Gematol. Pereliv. Krovi 7 1981 29 33

Twort F. W. An investigation on the nature of ultramicroscopic viruses. Lancet ii 1915 1241

Twort F. W. Researches on dysentery. Br. J. Exp. Pathol. 1 1920 237 243

Van Helvoort T. Bacteriological and physiological research styles in the early controversy on the nature of the bacteriophage phenomenon. Med. Hist. 3 1992 243 270

Vieu J. F. Guillermet F. Minck R. Nicolle P. Donnees actuelles sur les applications therapeutiques des bacteriophages. Bull. Acad. Natl. Med. 163 1979 61

Weber-Dabrowska B. Dabrowski M. Slopek S. Studies on bacteriophage penetration in patients subjected to phage therapy. Arch. Immunol. Ther. Exp. 35 1987 563 568

Weber-Dabrowska B. Zimecki M. Mulczyk M. Effective phage therapy is associated with normalization of cytokine production by blood cell cultures. Arch. Immunol. Ther. Exp. 48 2000 31 37

Yao J. D. C. Moellering R. C. Jr. Antimicrobial agents Manual of clinical microbiology 7th ed. Murray P. R. Baron E. J. Pfaller M. A. Tenover F. C. Yolken R. H. 1995 1474 1504 American Society for Microbiology Washington D.C.

Zhukov-Verezhnikov N. N. Peremitina L. D. Berillo E. A. Komissarov V. P. Bardymov V. M. Khvoles A. G. Ugryumov L. B. A study of the therapeutic effect of bacteriophage agents in a complex treatment of suppurative surgical diseases. Sov. Med. 12 1978 64 66